We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




First of Its Kind Technology Detects Glucose in Human Saliva

By LabMedica International staff writers
Posted on 30 Nov 2023

Blood tests are vital for assessing health, but they often involve uncomfortable procedures, including frequent finger pricks or blood draws by a phlebotomist. More...

Saliva, which shares many biomarkers with blood, has been considered as an alternative for monitoring health indicators like glucose levels. Traditional analysis of saliva for small molecules often requires lab equipment. Now, a new device capable of detecting glucose and adenosine monophosphate (AMP) in saliva with high sensitivity could simplify home health monitoring and eliminate the discomfort of traditional methods.

At the Université de Sherbrooke in Québec, Canada, researchers have adapted electrochemical aptamer-based (E-AB) biosensors, previously used for testing blood samples, to work with saliva. These biosensors generate an electrochemical signal when a custom-designed DNA or RNA aptamer binds to a specific target molecule. Focusing on glucose and AMP—a biomarker linked to gum disease—the team modified existing DNA aptamers to enhance their sensitivity and mounted them on gold electrodes to create the E-AB biosensors. Saliva samples were gathered from participants and combined for testing. The innovative aspect of this approach lies in its simplicity: the biosensors can be directly immersed in saliva without any additional preparation or reagents, making it feasible for at-home patient use.

The researchers observed that their devices could deliver results in just 30 seconds, remained effective in pure saliva for up to three days, and maintained their sensitivity for a week with proper washing after each use. The glucose sensor demonstrated high specificity for its target, and both AMP and glucose sensors could detect these biomarkers at concentrations lower than those usually present in saliva. This breakthrough, particularly in glucose detection in human saliva, holds promise for making health monitoring less invasive and more manageable for individuals with chronic conditions like diabetes.

Related Links:
Université de Sherbrooke


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Silver Member
Quality Control Material
Multichem ID-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.